GlassScriptPhysician profile
Marcy J Abel
NPI 1952388977
$22,342.34
in general payments reported to CMS, 2019-2025
40 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,603 · 2020: $3,432 · 2021: $1,540 · 2022: $3,083 · 2023: $1,620 · 2024: $1,447 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,581 · Education: $84.99 · Entertainment: $17.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,581.20 |
| Education | $84.99 |
| Entertainment | $17.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14,811.41 | 2019-2025 | Upsylon, Solyx Sis System, Advantage System |
| Axonics, INC. | $1,790.43 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $957.65 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $775.74 | 2023-2025 | Gemtesa |
| Caldera Medical, INC | $631.33 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $440.14 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Coloplast Corp | $371.16 | 2019-2025 | Speedicath |
| Abbvie INC. | $311.25 | 2022-2025 | Botox |
| Medtronic, INC. | $278.81 | 2021-2025 | Altaviva, Interstim |
| Allergan, INC. | $256.73 | 2019-2021 | |
| Rochester Medical Corporation | $212.81 | 2019-2022 | |
| Urovant Sciences INC | $161.81 | 2021-2022 | |
| Urogen Pharma, INC. | $141.61 | 2020 | |
| Femselect INC. | $124.29 | 2025 | Enplace |
| Hologic Sales and Service, LLC | $117.93 | 2024 | Coolseal Generator |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $93.53 | 2021-2023 | Infyna Chic |
| Kowa Pharmaceuticals America, INC. | $93.33 | 2022-2023 | Seglentis |
| Laborie Medical Technologies Corp. | $83.25 | 2021-2025 | Urgent PC Neuromodulation System |
| Convatec INC. | $65.41 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $64.75 | 2019 | |
| Medtronic USA, INC. | $54.51 | 2019-2020 | |
| Abc Home Medical Supply, INC. | $40.30 | 2022-2024 | |
| Valencia Technologies Corporation | $39.45 | 2025 | Ecoin Device Kit |
| Millicent US INC | $38.97 | 2023-2024 | Intrarosa, Femring |
| Provepharm INC. | $36.98 | 2024-2025 | Bludigo |
| 180 Medical, INC. | $36.67 | 2021-2025 | |
| Pfizer INC. | $33.71 | 2020 | |
| Travere Therapeutics, INC. | $33.20 | 2019 | |
| Duchesnay USA Incorporated | $32.15 | 2019 | |
| Calyxo, INC. | $28.84 | 2025 | Cvac Aspiration System |
| Zyla Life Sciences, INC. | $24.79 | 2019 | |
| Dentsply Ih Ab | $24.76 | 2024 | Lofric |
| Cook Medical LLC | $21.06 | 2024 | Cook, Litho 150 |
| Photocure INC | $17.67 | 2024 | Cysview |
| Mission Pharmacal Company | $17.43 | 2023 | Uribel |
| Antares Pharma, INC. | $17.14 | 2022 | |
| Therapeuticsmd, INC. | $16.71 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.13 | 2019 | |
| Coopersurgical, INC. | $14.86 | 2019 | |
| Ethicon US, LLC | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcy Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.